Markets watch chip rally as health insurers sink on Medicare Advantage payment proposal

U.S. markets opened Tuesday, January 27, 2026, with investors trying to reconcile two competing forces: renewed strength in chip stocks tied to AI-driven demand and a sudden selloff in health insurance shares triggered by Washington’s latest Medicare proposal. Futures for the S&P 500 and Nasdaq were modestly higher in early trading, while Dow futures lagged as big insurers came under pressure.

Health insurers drop after a thin 2027 payment proposal

The sharpest early move centered on insurers with large Medicare Advantage exposure. A proposal from the Centers for Medicare & Medicaid Services signaled only a 0.09% payment increase for 2027, far below what the industry had been expecting. The headline number immediately fed fears that margins could tighten just as medical costs remain difficult to forecast and competition intensifies.

Investors also weighed ongoing scrutiny of Medicare Advantage practices, including reporting around diagnostic coding and federal investigations. The combination—payment uncertainty plus regulatory risk—hit sentiment quickly, with multiple large names falling hard in premarket activity.

Chips lead as Micron expands in Singapore

On the other side of the ledger, chipmakers outperformed. Micron’s announcement that it has broken ground on a major new manufacturing facility in Singapore helped push the sector higher. The company described the project as roughly a $24 billion investment over the next decade, positioning it to serve rising demand for memory products linked to data centers and AI workloads.

Micron said production at the new facility is expected to begin in the second half of 2028, and it also pointed to progress on high-bandwidth memory work at the site. Traders treated the plan as both a long-run capacity signal and a near-term endorsement of tight supply conditions that have supported pricing across parts of the memory market.

Earnings season and the Fed frame the next move

The session landed in the middle of a heavy earnings stretch, with several well-known industrial and consumer-facing companies reporting results. Investors paid particular attention to guidance, since it can reveal whether companies see 2026 demand holding up or cooling under still-elevated borrowing costs.

Meanwhile, the Federal Reserve’s first policy decision of 2026 remained a dominant macro focus. With markets largely expecting no immediate rate change, investors looked for clarity on how policymakers interpret inflation progress and labor-market softness—and whether the timing of any future cuts has shifted.

In short, Tuesday’s “mixed” tape told a clear story: policy decisions—whether on health-care payments or interest rates—are driving just as much price action as corporate fundamentals. For traders, the question was whether chip strength could offset the drag from health insurance, and whether upcoming Fed messaging would add fuel or caution.